{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:40:30Z","timestamp":1785523230221,"version":"3.56.0"},"reference-count":156,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-026-04500-8","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T12:41:52Z","timestamp":1785156112000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Microbiome-guided cancer immunotherapy: immune mechanisms, resistance pathways, and translational opportunities for precision oncology"],"prefix":"10.1007","author":[{"given":"Ismail","family":"Amin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atef S.","family":"Elgebaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hend H.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled","family":"Abuelhaded","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled M.","family":"Alam-ElDein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Kamel","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimaa A.","family":"Farag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa","family":"Adel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Hamdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Elkhawanky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3487-1971","authenticated-orcid":false,"given":"Ahmed","family":"Mahdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,27]]},"reference":[{"key":"4500_CR1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.2174\/1389201022666210104115836","volume":"23","author":"MN Hajiagha","year":"2022","unstructured":"Hajiagha MN, Taghizadeh S, Asgharzadeh M, Dao S, Ganbarov K, K\u00f6se \u015e, et al. Gut microbiota and human body interactions; its impact on health: a review. Curr Pharm Biotechnol. 2022;23:4\u201314.","journal-title":"Curr Pharm Biotechnol"},{"key":"4500_CR2","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/s41419-021-03829-y","volume":"12","author":"Y Li","year":"2021","unstructured":"Li Y, Jin Y, Zhang J, Pan H, Wu L, Liu D, et al. Recovery of human gut microbiota genomes with third-generation sequencing. Cell Death Dis. 2021;12:569.","journal-title":"Cell Death Dis"},{"key":"4500_CR3","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1038\/s41423-020-00625-0","volume":"18","author":"CH Kim","year":"2021","unstructured":"Kim CH. Control of lymphocyte functions by gut microbiota-derived short-chain fatty acids. Cell Mol Immunol. 2021;18:1161\u201371.","journal-title":"Cell Mol Immunol"},{"key":"4500_CR4","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1007\/s12602-021-09903-3","volume":"14","author":"R Sharma","year":"2022","unstructured":"Sharma R. Emerging interrelationship between the gut microbiome and cellular senescence in the context of aging and disease: perspectives and therapeutic opportunities. Probiotics Antimicrob Proteins. 2022;14:648\u201363.","journal-title":"Probiotics Antimicrob Proteins"},{"key":"4500_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/foods10102312","volume":"10","author":"L Zhang","year":"2021","unstructured":"Zhang L, Zhang Z, Xu L, Zhang X. Maintaining the balance of intestinal flora through the diet: effective prevention of illness. Foods. 2021;10:2312.","journal-title":"Foods"},{"key":"4500_CR6","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41564-021-01021-8","volume":"7","author":"M Valles-Colomer","year":"2022","unstructured":"Valles-Colomer M, Bacigalupe R, Vieira-Silva S, Suzuki S, Darzi Y, Tito RY, et al. Variation and transmission of the human gut microbiota across multiple familial generations. Nat Microbiol. 2022;7:87\u201396.","journal-title":"Nat Microbiol"},{"key":"4500_CR7","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00248-022-02081-x","volume":"86","author":"A Pant","year":"2023","unstructured":"Pant A, Maiti TK, Mahajan D, Das B. Human gut microbiota and drug metabolism. Microb Ecol. 2023;86:97\u2013111.","journal-title":"Microb Ecol"},{"key":"4500_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70168","volume":"6","author":"Y Shen","year":"2025","unstructured":"Shen Y, Fan N, Ma S, Cheng X, Yang X, Wang G. Gut microbiota dysbiosis: pathogenesis, diseases, prevention, and therapy. MedComm. 2025;6:e70168.","journal-title":"MedComm"},{"key":"4500_CR9","doi-asserted-by":"publisher","DOI":"10.37349\/etat.2025.1002329","volume":"6","author":"G Singh","year":"2025","unstructured":"Singh G, Chaudhry Z, Boyadzhyan A, Sasaninia K, Rai V. Dysbiosis and colorectal cancer: conducive factors, biological and molecular role, and therapeutic prospectives. Exploration of Targeted Anti-tumor Therapy. 2025;6:1002329.","journal-title":"Exploration of Targeted Anti-tumor Therapy"},{"key":"4500_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1338918","volume":"14","author":"H Zhang","year":"2024","unstructured":"Zhang H, Shi Y, Lin C, He C, Wang S, Li Q, et al. Overcoming cancer risk in inflammatory bowel disease: new insights into preventive strategies and pathogenesis mechanisms including interactions of immune cells, cancer signaling pathways, and gut microbiota. Front Immunol. 2024;14:1338918.","journal-title":"Front Immunol"},{"key":"4500_CR11","doi-asserted-by":"publisher","first-page":"00708","DOI":"10.1128\/spectrum","volume":"9","author":"A Ishizaka","year":"2021","unstructured":"Ishizaka A, Koga M, Mizutani T, Parbie PK, Prawisuda D, Yusa N, et al. Unique gut microbiome in HIV patients on antiretroviral therapy (ART) suggests association with chronic inflammation. Microbiol Spect. 2021;9:00708\u201321. https:\/\/doi.org\/10.1128\/spectrum.","journal-title":"Microbiol Spect"},{"key":"4500_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23137348","volume":"23","author":"D Kociszewska","year":"2022","unstructured":"Kociszewska D, Vlajkovic S. Age-related hearing loss: the link between inflammaging, immunosenescence, and gut dysbiosis. Int J Mol Sci. 2022;23:7348.","journal-title":"Int J Mol Sci"},{"key":"4500_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13010100","volume":"13","author":"EK Anwer","year":"2025","unstructured":"Anwer EK, Ajagbe M, Sherif M, Musaibah AS, Mahmoud S, ElBanbi A, et al. Gut microbiota secondary metabolites: key roles in GI tract cancers and infectious diseases. Biomedicines. 2025;13:100.","journal-title":"Biomedicines"},{"key":"4500_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14215317","volume":"14","author":"Y He","year":"2022","unstructured":"He Y, Huang J, Li Q, Xia W, Zhang C, Liu Z, et al. Gut microbiota and tumor immune escape: a new perspective for improving tumor immunotherapy. Cancers. 2022;14:5317.","journal-title":"Cancers"},{"key":"4500_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26083733","volume":"26","author":"VA Ionescu","year":"2025","unstructured":"Ionescu VA, Diaconu CC, Gheorghe G, Mihai M-M, Diaconu CC, Bostan M, et al. Gut microbiota and colorectal cancer: a balance between risk and protection. Int J Mol Sci. 2025;26:3733.","journal-title":"Int J Mol Sci"},{"key":"4500_CR16","doi-asserted-by":"publisher","DOI":"10.1172\/JCI157340","author":"S Pal","year":"2022","unstructured":"Pal S, Perrien DS, Yumoto T, Faccio R, Stoica A, Adams J, et al. The microbiome restrains melanoma bone growth by promoting intestinal NK and Th1 cell homing to bone. J Clin Invest. 2022. https:\/\/doi.org\/10.1172\/JCI157340.","journal-title":"J Clin Invest"},{"key":"4500_CR17","doi-asserted-by":"publisher","first-page":"653","DOI":"10.2174\/0113892029382696251125102036","volume":"26","author":"G Yang","year":"2025","unstructured":"Yang G, Yu J, Deng X, Dai J, Liu Q. Unveiling the role of sialylation-related lncRNAs in lung adenocarcinoma: a new prognostic model. Curr Genomics. 2025;26:653\u201372.","journal-title":"Curr Genomics"},{"key":"4500_CR18","doi-asserted-by":"publisher","DOI":"10.2174\/0113892029392506251115053421","author":"SK Kadiri","year":"2026","unstructured":"Kadiri SK, Tiwari P. Genetic uncertainties fueling cholangiocarcinoma progression. Curr Genomics. 2026. https:\/\/doi.org\/10.2174\/0113892029392506251115053421.","journal-title":"Curr Genomics"},{"issue":"6","key":"4500_CR19","doi-asserted-by":"publisher","first-page":"563","DOI":"10.2174\/0113892029406752251110100414","volume":"26","author":"K Aggarwal","year":"2026","unstructured":"Aggarwal K, Jindal P, Akash V, Patel P, Das Kurmi B. Transforming cancer care: genomic profiling, ai, and next-generation drug delivery systems. Curr Genom. 2026;26(6):563\u201380.","journal-title":"Curr Genom"},{"key":"4500_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12122776","volume":"12","author":"H Farhadi Rad","year":"2024","unstructured":"Farhadi Rad H, Tahmasebi H, Javani S, Hemati M, Zakerhamidi D, Hosseini M, et al. Microbiota and cytokine modulation: innovations in enhancing anticancer immunity and personalized cancer therapies. Biomedicines. 2024;12:2776.","journal-title":"Biomedicines"},{"key":"4500_CR21","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/s41571-023-00803-9","volume":"20","author":"RC Simpson","year":"2023","unstructured":"Simpson RC, Shanahan ER, Scolyer RA, Long GV. Towards modulating the gut microbiota to enhance the efficacy of immune-checkpoint inhibitors. Nat Rev Clin Oncol. 2023;20:697\u2013715.","journal-title":"Nat Rev Clin Oncol"},{"key":"4500_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1096551","volume":"13","author":"M Wang","year":"2023","unstructured":"Wang M, Zhang L, Chang W, Zhang Y. The crosstalk between the gut microbiota and tumor immunity: implications for cancer progression and treatment outcomes. Front Immunol. 2023;13:1096551.","journal-title":"Front Immunol"},{"key":"4500_CR23","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1126\/science.aac4255","volume":"350","author":"A Sivan","year":"2015","unstructured":"Sivan A, Corrales L, Hubert N, Williams JB, Aquino-Michaels K, Earley ZM, et al. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti\u2013PD-L1 efficacy. Science. 2015;350:1084\u20139.","journal-title":"Science"},{"key":"4500_CR24","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1126\/science.abf3363","volume":"371","author":"D Davar","year":"2021","unstructured":"Davar D, Dzutsev AK, McCulloch JA, Rodrigues RR, Chauvin J-M, Morrison RM, et al. Fecal microbiota transplant overcomes resistance to anti\u2013PD-1 therapy in melanoma patients. Science. 2021;371:595\u2013602.","journal-title":"Science"},{"key":"4500_CR25","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1038\/s41423-025-01326-2","volume":"22","author":"M Xie","year":"2025","unstructured":"Xie M, Li X, Lau HC-H, Yu J. The gut microbiota in cancer immunity and immunotherapy. Cell Mol Immunol. 2025;22:1012\u201331.","journal-title":"Cell Mol Immunol"},{"key":"4500_CR26","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13045-024-01541-w","volume":"17","author":"Z Li","year":"2024","unstructured":"Li Z, Xiong W, Liang Z, Wang J, Zeng Z, Ko\u0142at D, et al. Critical role of the gut microbiota in immune responses and cancer immunotherapy. J Hematol Oncol. 2024;17:33.","journal-title":"J Hematol Oncol"},{"key":"4500_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01765-9","volume":"9","author":"A Hu","year":"2024","unstructured":"Hu A, Sun L, Lin H, Liao Y, Yang H, Mao Y. Harnessing innate immune pathways for therapeutic advancement in cancer. Signal Transduct Target Ther. 2024;9:68.","journal-title":"Signal Transduct Target Ther"},{"key":"4500_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","volume":"39","author":"DS Chen","year":"2013","unstructured":"Chen DS, Mellman I. Oncology meets immunology: the cancer-immunity cycle. Immunity. 2013;39:1\u201310.","journal-title":"Immunity"},{"key":"4500_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.812774","volume":"13","author":"T Duan","year":"2022","unstructured":"Duan T, Du Y, Xing C, Wang HY, Wang R-F. Toll-like receptor signaling and its role in cell-mediated immunity. Front Immunol. 2022;13:812774. https:\/\/doi.org\/10.3389\/fimmu.2022.812774.","journal-title":"Front Immunol"},{"key":"4500_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/nu14245361","volume":"14","author":"G Ramos Meyers","year":"2022","unstructured":"Ramos Meyers G, Samouda H, Bohn T. Short chain fatty acid metabolism in relation to gut microbiota and genetic variability. Nutrients. 2022;14:5361. https:\/\/doi.org\/10.3390\/nu14245361.","journal-title":"Nutrients"},{"key":"4500_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115276","volume":"165","author":"H Duan","year":"2023","unstructured":"Duan H, Wang L, Huangfu M, Li H. The impact of microbiota-derived short-chain fatty acids on macrophage activities in disease: mechanisms and therapeutic potentials. Biomed Pharmacother. 2023;165:115276. https:\/\/doi.org\/10.1016\/j.biopha.2023.115276.","journal-title":"Biomed Pharmacother"},{"key":"4500_CR32","first-page":"716","volume":"12","author":"J Bourque","year":"2023","unstructured":"Bourque J, Hawiger D. Activation, amplification, and ablation as dynamic mechanisms of dendritic cell maturation. Biology (Basel). 2023;12:716.","journal-title":"Biology (Basel)"},{"key":"4500_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1352946","volume":"15","author":"M Luo","year":"2024","unstructured":"Luo M, Zhao F, Cheng H, Su M, Wang Y. Macrophage polarization: an important role in inflammatory diseases. Front Immunol. 2024;15:1352946. https:\/\/doi.org\/10.3389\/fimmu.2024.1352946.","journal-title":"Front Immunol"},{"key":"4500_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1662906","volume":"16","author":"MB Gonzatti","year":"2025","unstructured":"Gonzatti MB, Keller AC. Invariant natural killer T lymphocytes as natural sensors for microbes: a two-edged sword in liver diseases. Front Immunol. 2025;16:1662906.","journal-title":"Front Immunol"},{"key":"4500_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.micres.2024.127871","volume":"288","author":"T Yin","year":"2024","unstructured":"Yin T, Zhang X, Xiong Y, Li B, Guo D, Sha Z, et al. Exploring gut microbial metabolites as key players in inhibition of cancer progression: mechanisms and therapeutic implications. Microbiol Res. 2024;288:127871. https:\/\/doi.org\/10.1016\/j.micres.2024.127871.","journal-title":"Microbiol Res"},{"key":"4500_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2025.118559","volume":"192","author":"M Jayaprakash","year":"2025","unstructured":"Jayaprakash M, Vijaya Kumar D, Chakraborty G, Chakraborty A, Kumar V. Bacteria-mediated cancer therapy (BMCT): therapeutic applications, clinical insights, and the microbiome as an emerging hallmark of cancer. Biomed Pharmacother. 2025;192:118559. https:\/\/doi.org\/10.1016\/j.biopha.2025.118559.","journal-title":"Biomed Pharmacother"},{"key":"4500_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13051037","volume":"13","author":"SE Fenton","year":"2021","unstructured":"Fenton SE, Saleiro D, Platanias LC. Type I and II interferons in the anti-tumor immune response. Cancers. 2021;13:1037. https:\/\/doi.org\/10.3390\/cancers13051037.","journal-title":"Cancers"},{"key":"4500_CR38","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.4161\/onci.21176","volume":"1","author":"T Fujimura","year":"2012","unstructured":"Fujimura T, Kambayashi Y, Aiba S. Crosstalk between regulatory T cells (Tregs) and myeloid derived suppressor cells (MDSCs) during melanoma growth. Oncoimmunology. 2012;1:1433\u20134. https:\/\/doi.org\/10.4161\/onci.21176.","journal-title":"Oncoimmunology"},{"key":"4500_CR39","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1126\/science.aaz7015","volume":"374","author":"CN Spencer","year":"2021","unstructured":"Spencer CN, McQuade JL, Gopalakrishnan V, McCulloch JA, Vetizou M, Cogdill AP, et al. Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response. Science. 2021;374:1632\u201340.","journal-title":"Science"},{"key":"4500_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2025.1677795","volume":"16","author":"A Gusmaulemova","year":"2025","unstructured":"Gusmaulemova A, Kurentay B, Bayanbek D, Kulmambetova G. Comparative insights into Fusobacterium nucleatum and Helicobacter pylori in human cancers. Front Microbiol. 2025;16:1677795. https:\/\/doi.org\/10.3389\/fmicb.2025.1677795.","journal-title":"Front Microbiol"},{"key":"4500_CR41","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.immuni.2022.01.006","volume":"55","author":"K Hezaveh","year":"2022","unstructured":"Hezaveh K, Shinde RS, Kl\u00f6tgen A, Halaby MJ, Lamorte S, Ciudad MT, et al. Tryptophan-derived microbial metabolites activate the aryl hydrocarbon receptor in tumor-associated macrophages to suppress anti-tumor immunity. Immunity. 2022;55:324-340.e328. https:\/\/doi.org\/10.1016\/j.immuni.2022.01.006.","journal-title":"Immunity"},{"key":"4500_CR42","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-082323-114522","author":"HM Zarour","year":"2025","unstructured":"Zarour HM, Trinchieri G. Harnessing the microbiome in cancer immunotherapy: regulation, prediction, and therapeutic targeting. Annu Rev Immunol. 2025. https:\/\/doi.org\/10.1146\/annurev-immunol-082323-114522.","journal-title":"Annu Rev Immunol"},{"key":"4500_CR43","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/science.aan3706","volume":"359","author":"B Routy","year":"2018","unstructured":"Routy B, Le Chatelier E, Derosa L, Duong CP, Alou MT, Daill\u00e8re R, et al. Gut microbiome influences efficacy of PD-1\u2013based immunotherapy against epithelial tumors. Science. 2018;359:91\u20137.","journal-title":"Science"},{"key":"4500_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2023.100923","volume":"43","author":"M Zeriouh","year":"2023","unstructured":"Zeriouh M, Raskov H, Kvich L, G\u00f6genur I, Bennedsen ALB. Checkpoint inhibitor responses can be regulated by the gut microbiota\u2013a systematic review. Neoplasia. 2023;43:100923.","journal-title":"Neoplasia"},{"key":"4500_CR45","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1126\/science.aan4236","volume":"359","author":"V Gopalakrishnan","year":"2018","unstructured":"Gopalakrishnan V, Spencer CN, Nezi L, Reuben A, Andrews MC, Karpinets TV, et al. Gut microbiome modulates response to anti\u2013PD-1 immunotherapy in melanoma patients. Science. 2018;359:97\u2013103.","journal-title":"Science"},{"key":"4500_CR46","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1126\/science.aao3290","volume":"359","author":"V Matson","year":"2018","unstructured":"Matson V, Fessler J, Bao R, Chongsuwat T, Zha Y, Alegre M-L, et al. The commensal microbiome is associated with anti\u2013PD-1 efficacy in metastatic melanoma patients. Science. 2018;359:104\u20138.","journal-title":"Science"},{"key":"4500_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1675677","volume":"16","author":"H Duan","year":"2025","unstructured":"Duan H, Xu B, Luo P, Chen T, Zou J. Microbial metabolites and their influence on the tumor microenvironment. Front Immunol. 2025;16:1675677.","journal-title":"Front Immunol"},{"key":"4500_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1557959","volume":"15","author":"C Zhang","year":"2025","unstructured":"Zhang C, Wang Y, Cheng L, Cao X, Liu C. Gut microbiota in colorectal cancer: a review of its influence on tumor immune surveillance and therapeutic response. Front Oncol. 2025;15:1557959.","journal-title":"Front Oncol"},{"key":"4500_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/gastro\/gox031","volume":"6","author":"S Zou","year":"2018","unstructured":"Zou S, Fang L, Lee M-H. Dysbiosis of gut microbiota in promoting the development of colorectal cancer. Gastroenterol Rep. 2018;6:1\u201312.","journal-title":"Gastroenterol Rep"},{"key":"4500_CR50","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1146\/annurev-pathmechdis-032221-115501","volume":"17","author":"L Maiorino","year":"2022","unstructured":"Maiorino L, Da\u00dfler-Plenker J, Sun L, Egeblad M. Innate immunity and cancer pathophysiology. Annu Rev Pathol Mech Dis. 2022;17:425\u201357.","journal-title":"Annu Rev Pathol Mech Dis"},{"key":"4500_CR51","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1084\/jem.20181939","volume":"216","author":"W Zhu","year":"2019","unstructured":"Zhu W, Miyata N, Winter MG, Arenales A, Hughes ER, Spiga L, et al. Editing of the gut microbiota reduces carcinogenesis in mouse models of colitis-associated colorectal cancer. J Exp Med. 2019;216:2378\u201393.","journal-title":"J Exp Med"},{"key":"4500_CR52","doi-asserted-by":"publisher","first-page":"258","DOI":"10.7150\/ijbs.119630","volume":"22","author":"Q Li","year":"2026","unstructured":"Li Q, Xia S, Zhang X, Liu Y, Xiao X, Yang J. Gut microbiota-driven pathways linking chronic stress to tumor progression. Int J Biol Sci. 2026;22:258.","journal-title":"Int J Biol Sci"},{"key":"4500_CR53","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1056\/NEJMoa1708423","volume":"378","author":"IJ Choi","year":"2018","unstructured":"Choi IJ, Kook M-C, Kim Y-I, Cho S-J, Lee JY, Kim CG, et al. Helicobacter pylori therapy for the prevention of metachronous gastric cancer. N Engl J Med. 2018;378:1085\u201395.","journal-title":"N Engl J Med"},{"key":"4500_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.1141215","volume":"11","author":"MP DiPalma","year":"2023","unstructured":"DiPalma MP, Blattman JN. The impact of microbiome dysbiosis on T cell function within the tumor microenvironment (TME). Front Cell Dev Biol. 2023;11:1141215.","journal-title":"Front Cell Dev Biol"},{"key":"4500_CR55","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1126\/science.1224820","volume":"338","author":"JC Arthur","year":"2012","unstructured":"Arthur JC, Perez-Chanona E, M\u00fchlbauer M, Tomkovich S, Uronis JM, Fan T-J, et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science. 2012;338:120\u20133.","journal-title":"Science"},{"key":"4500_CR56","unstructured":"Pleguezuelos-Manzano, C.; Puschhof, J.; Rosendahl Huber, A.; van Hoeck, A.; Wood, H.M.; Nomburg, J.; Gurjao, C.; Manders, F.; Dalmasso, G.; Stege, P.B. Mutational signature in colorectal cancer caused by genotoxic pks+ E. coli. Nature 2020, 580, 269\u2013273."},{"key":"4500_CR57","doi-asserted-by":"publisher","DOI":"10.4251\/wjgo.v17.i8.107453","volume":"17","author":"J-Y Chen","year":"2025","unstructured":"Chen J-Y, Wen J-Y, Lin J-L, Li Y, Wu Y-Z, Lou L-Q, et al. Deoxycholic acid induces reactive oxygen species accumulation and promotes colorectal cancer cell apoptosis through the CaMKII-Ca2+ pathway. World J Gastrointest Oncol. 2025;17:107453.","journal-title":"World J Gastrointest Oncol"},{"key":"4500_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01953-7","volume":"9","author":"Q Li","year":"2024","unstructured":"Li Q, Geng S, Luo H, Wang W, Mo Y-Q, Luo Q, et al. Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy. Signal Transduct Target Ther. 2024;9:266.","journal-title":"Signal Transduct Target Ther"},{"key":"4500_CR59","doi-asserted-by":"publisher","first-page":"153303382513319","DOI":"10.1177\/15330338251331960","volume":"24","author":"K Xu","year":"2025","unstructured":"Xu K, Motiwala Z, Corona-Avila I, Makhanasa D, Alkahalifeh L, Khan MW. The Gut Microbiome and Its Multifaceted Role in Cancer Metabolism, Initiation, and Progression: Insights and Therapeutic Implications. Technol Cancer Res Treat. 2025;24:15330338251331960.","journal-title":"Technol Cancer Res Treat"},{"key":"4500_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17030368","volume":"17","author":"L Galasso","year":"2025","unstructured":"Galasso L, Termite F, Mignini I, Esposto G, Borriello R, Vitale F, et al. Unraveling the role of Fusobacterium nucleatum in colorectal cancer: molecular mechanisms and pathogenic insights. Cancers (Basel). 2025;17:368.","journal-title":"Cancers (Basel)"},{"key":"4500_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/s13027-025-00676-w","volume":"20","author":"AS Kowsarkhizi","year":"2025","unstructured":"Kowsarkhizi AS, Yousefi B, Rahimi A, Aliramezani A. Targeting Fusobacterium nucleatum in colorectal cancer: therapeutic strategies and future directions. Infect Agent Cancer. 2025;20:70.","journal-title":"Infect Agent Cancer"},{"key":"4500_CR62","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1097\/MS9.0000000000004287","volume":"88","author":"MS Mehmood","year":"2026","unstructured":"Mehmood MS, Danaf N. Bacteroides fragilis toxin in colorectal tumors activates STAT3 and drives microsatellite instability. Ann Med Surg (Lond). 2026;88:957\u20138.","journal-title":"Ann Med Surg (Lond)"},{"key":"4500_CR63","first-page":"djw029","volume":"108","author":"M Kwa","year":"2016","unstructured":"Kwa M, Plottel CS, Blaser MJ, Adams S. The intestinal microbiome and estrogen receptor\u2013positive female breast cancer. J Natl Cancer Inst. 2016;108:djw029.","journal-title":"J Natl Cancer Inst"},{"key":"4500_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2025.09.008","author":"S Xia","year":"2025","unstructured":"Xia S, Jia D, Wang L. Microbiota: a dawn for cancer metastasis therapy. Trends Mol Med. 2025. https:\/\/doi.org\/10.1016\/j.molmed.2025.09.008.","journal-title":"Trends Mol Med"},{"key":"4500_CR65","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/path.5047","volume":"244","author":"B Goodman","year":"2018","unstructured":"Goodman B, Gardner H. The microbiome and cancer. J Pathol. 2018;244:667\u201376.","journal-title":"J Pathol"},{"key":"4500_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-08211-w","author":"J Jia","year":"2025","unstructured":"Jia J, Gao W, Wang C, Liu L, Li Y, Sun Z, et al. Intratumoral microbiota remodeling of the tumor microenvironment impact solid tumor immunotherapy. Cell Death Dis. 2025. https:\/\/doi.org\/10.1038\/s41419-025-08211-w.","journal-title":"Cell Death Dis"},{"key":"4500_CR67","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1506577","volume":"15","author":"P Fang","year":"2025","unstructured":"Fang P, Yang J, Zhang H, Shuai D, Li M, Chen L, et al. Emerging roles of intratumoral microbiota: a key to novel cancer therapies. Front Oncol. 2025;15:1506577.","journal-title":"Front Oncol"},{"key":"4500_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/s41522-025-00678-x","volume":"11","author":"J Sun","year":"2025","unstructured":"Sun J, Song S, Liu J, Chen F, Li X, Wu G. Gut microbiota as a new target for anticancer therapy: from mechanism to means of regulation. NPJ Biofilms Microbiomes. 2025;11:43.","journal-title":"NPJ Biofilms Microbiomes"},{"key":"4500_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.tjnut.2025.101300","author":"C Morel","year":"2025","unstructured":"Morel C, Li R, Luces CF, Brougham MF, Pascual-Gazquez JF, Iniesta RR, et al. Interventions targeting the gut microbiome to improve cancer treatment outcomes and their gastrointestinal side effects: a systematic review and meta-analysis. J Nutr. 2025. https:\/\/doi.org\/10.1016\/j.tjnut.2025.101300.","journal-title":"J Nutr"},{"key":"4500_CR70","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s13690-025-01685-2","volume":"83","author":"Y Cui","year":"2025","unstructured":"Cui Y, Xu J, Zheng Q, Wang J, Xu C, Zhang M, et al. Genetically proxied gut microbiota and cancer risk: a scoping review of Mendelian randomization studies. Arch Public Health. 2025;83:209.","journal-title":"Arch Public Health"},{"issue":"5","key":"4500_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s42255-025-01287-w","volume":"7","author":"A Nobels","year":"2025","unstructured":"Nobels A, van Marcke C, Jordan BF, Van Hul M, Cani PD. The gut microbiome and cancer: from tumorigenesis to therapy. Nat Metab. 2025;7(5):1\u201323.","journal-title":"Nat Metab"},{"key":"4500_CR72","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202207366","volume":"10","author":"Q Yang","year":"2023","unstructured":"Yang Q, Wang B, Zheng Q, Li H, Meng X, Zhou F, et al. A review of gut microbiota\u2010derived metabolites in tumor progression and cancer therapy. Adv Sci. 2023;10:2207366.","journal-title":"Adv Sci"},{"key":"4500_CR73","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1126\/science.1191175","volume":"330","author":"BD Wallace","year":"2010","unstructured":"Wallace BD, Wang H, Lane KT, Scott JE, Orans J, Koo JS, et al. Alleviating cancer drug toxicity by inhibiting a bacterial enzyme. Science. 2010;330:831\u20135.","journal-title":"Science"},{"key":"4500_CR74","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-32860-x","volume":"8","author":"M Luu","year":"2018","unstructured":"Luu M, Weigand K, Wedi F, Breidenbend C, Leister H, Pautz S, et al. Regulation of the effector function of CD8+ T cells by gut microbiota-derived metabolite butyrate. Sci Rep. 2018;8:14430.","journal-title":"Sci Rep"},{"key":"4500_CR75","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s41591-019-0377-7","volume":"25","author":"BA Helmink","year":"2019","unstructured":"Helmink BA, Khan MW, Hermann A, Gopalakrishnan V, Wargo JA. The microbiome, cancer, and cancer therapy. Nat Med. 2019;25:377\u201388.","journal-title":"Nat Med"},{"key":"4500_CR76","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1126\/science.abb5920","volume":"371","author":"EN Baruch","year":"2021","unstructured":"Baruch EN, Youngster I, Ben-Betzalel G, Ortenberg R, Lahat A, Katz L, et al. Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients. Science. 2021;371:602\u20139. https:\/\/doi.org\/10.1126\/science.abb5920.","journal-title":"Science"},{"key":"4500_CR77","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s12029-025-01368-9","volume":"57","author":"M Alnaggar","year":"2026","unstructured":"Alnaggar M, Chen Y, Wang C, Wang S, Zhu F, Lin Y, et al. Synergistic effect of fecal microbiota transplantation, \u03b3\u03b4T cell immunotherapy, and pembrolizumab in refractory advanced pancreatic cancer: a case report. J Gastrointest Cancer. 2026;57:23.","journal-title":"J Gastrointest Cancer"},{"key":"4500_CR78","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.823288","author":"J Feng","year":"2022","unstructured":"Feng J, Gao M, Zhao C, Yang J, Gao H, Lu X, et al. Oral administration of probiotics reduces chemotherapy-induced diarrhea and oral mucositis: a systematic review and meta-analysis. Frontiers in Nutrition. 2022. https:\/\/doi.org\/10.3389\/fnut.2022.823288.","journal-title":"Frontiers in Nutrition"},{"key":"4500_CR79","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.cell.2017.07.008","volume":"170","author":"T Yu","year":"2017","unstructured":"Yu T, Guo F, Yu Y, Sun T, Ma D, Han J, et al. Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy. Cell. 2017;170:548.","journal-title":"Cell"},{"key":"4500_CR80","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1007\/s11427-024-2831-x","volume":"68","author":"R Zhang","year":"2025","unstructured":"Zhang R, Zhang X, Lau HCH, Yu J. Gut microbiota in cancer initiation, development and therapy. Sci China Life Sci. 2025;68:1283\u2013308.","journal-title":"Sci China Life Sci"},{"key":"4500_CR81","doi-asserted-by":"publisher","DOI":"10.1126\/science.aay9097","volume":"370","author":"H Guo","year":"2020","unstructured":"Guo H, Chou W-C, Lai Y, Liang K, Tam JW, Brickey WJ, et al. Multi-omics analyses of radiation survivors identify radioprotective microbes and metabolites. Science. 2020;370:eaay9097.","journal-title":"Science"},{"key":"4500_CR82","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1172\/jci124332","volume":"130","author":"M Uribe-Herranz","year":"2020","unstructured":"Uribe-Herranz M, Rafail S, Beghi S, Gil-de-G\u00f3mez L, Verginadis I, Bittinger K, et al. Gut microbiota modulate dendritic cell antigen presentation and radiotherapy-induced antitumor immune response. J Clin Invest. 2020;130:466\u201379. https:\/\/doi.org\/10.1172\/jci124332.","journal-title":"J Clin Invest"},{"key":"4500_CR83","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1298264","volume":"13","author":"L Van Dingenen","year":"2023","unstructured":"Van Dingenen L, Segers C, Wouters S, Mysara M, Leys N, Kumar-Singh S, et al. Dissecting the role of the gut microbiome and fecal microbiota transplantation in radio-and immunotherapy treatment of colorectal cancer. Front Cell Infect Microbiol. 2023;13:1298264.","journal-title":"Front Cell Infect Microbiol"},{"key":"4500_CR84","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24331-1","volume":"12","author":"M Luu","year":"2021","unstructured":"Luu M, Riester Z, Baldrich A, Reichardt N, Yuille S, Busetti A, et al. Microbial short-chain fatty acids modulate CD8+ T cell responses and improve adoptive immunotherapy for cancer. Nat Commun. 2021;12:4077.","journal-title":"Nat Commun"},{"key":"4500_CR85","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1126\/science.aah5043","volume":"357","author":"LT Geller","year":"2017","unstructured":"Geller LT, Barzily-Rokni M, Danino T, Jonas OH, Shental N, Nejman D, et al. Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine. Science. 2017;357:1156\u201360.","journal-title":"Science"},{"key":"4500_CR86","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1038\/s41564-022-01226-5","volume":"7","author":"P Spanogiannopoulos","year":"2022","unstructured":"Spanogiannopoulos P, Kyaw TS, Guthrie BG, Bradley PH, Lee JV, Melamed J, et al. Host and gut bacteria share metabolic pathways for anti-cancer drug metabolism. Nat Microbiol. 2022;7:1605\u201320.","journal-title":"Nat Microbiol"},{"key":"4500_CR87","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1038\/s41591-019-0498-z","volume":"25","author":"S Chowdhury","year":"2019","unstructured":"Chowdhury S, Castro S, Coker C, Hinchliffe TE, Arpaia N, Danino T. Programmable bacteria induce durable tumor regression and systemic antitumor immunity. Nat Med. 2019;25:1057\u201363.","journal-title":"Nat Med"},{"key":"4500_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2025.105085","author":"C-Y Hsu","year":"2025","unstructured":"Hsu C-Y, Polatova D, Hamad RH, Patel PN, Akram M, Singh G, et al. Phage therapy in cancer treatment: mechanisms, emerging innovations, and translational progress. Crit Rev Oncol Hematol. 2025. https:\/\/doi.org\/10.1016\/j.critrevonc.2025.105085.","journal-title":"Crit Rev Oncol Hematol"},{"key":"4500_CR89","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1559480","volume":"16","author":"M Eslami","year":"2025","unstructured":"Eslami M, Naderian R, Bahar A, Babaeizad A, Rezanavaz Gheshlagh S, Oksenych V, et al. Microbiota as diagnostic biomarkers: advancing early cancer detection and personalized therapeutic approaches through microbiome profiling. Front Immunol. 2025;16:1559480.","journal-title":"Front Immunol"},{"key":"4500_CR90","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10040827","volume":"10","author":"C-G Lee","year":"2022","unstructured":"Lee C-G, Hwang S, Gwon S-Y, Park C, Jo M, Hong J-E, et al. Bacteroides fragilis toxin induces intestinal epithelial cell secretion of interleukin-8 by the E-cadherin\/\u03b2-catenin\/NF-\u03baB dependent pathway. Biomedicines. 2022;10:827.","journal-title":"Biomedicines"},{"key":"4500_CR91","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.chom.2018.05.012","volume":"23","author":"K Makki","year":"2018","unstructured":"Makki K, Deehan EC, Walter J, B\u00e4ckhed F. The impact of dietary fiber on gut microbiota in host health and disease. Cell Host Microbe. 2018;23:705\u201315.","journal-title":"Cell Host Microbe"},{"key":"4500_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.122462","volume":"341","author":"JB de Souza","year":"2024","unstructured":"de Souza JB, de Almeida Campos LA, Palacio SB, Brelaz-de-Castro MCA, Cavalcanti IMF. Prevalence and implications of pKs-positive Escherichia coli in colorectal cancer. Life Sci. 2024;341:122462.","journal-title":"Life Sci"},{"key":"4500_CR93","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/j.tim.2022.05.010","volume":"30","author":"CV Chagneau","year":"2022","unstructured":"Chagneau CV, Payros D, Tang-Fichaux M, Auvray F, Nougayr\u00e8de J-P, Oswald E. The pks island: a bacterial Swiss army knife? Colibactin: beyond DNA damage and cancer. Trends Microbiol. 2022;30:1146\u201359.","journal-title":"Trends Microbiol"},{"key":"4500_CR94","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1038\/s41564-019-0541-3","volume":"4","author":"X Long","year":"2019","unstructured":"Long X, Wong CC, Tong L, Chu ES, Ho Szeto C, Go MY, et al. Peptostreptococcus anaerobius promotes colorectal carcinogenesis and modulates tumour immunity. Nat Microbiol. 2019;4:2319\u201330.","journal-title":"Nat Microbiol"},{"key":"4500_CR95","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-82465-0","volume":"11","author":"MA Osman","year":"2021","unstructured":"Osman MA, Neoh H-M, Ab Mutalib N-S, Chin S-F, Mazlan L, Raja Ali RA, et al. Parvimonas micra, Peptostreptococcus stomatis, Fusobacterium nucleatum and Akkermansia muciniphila as a four-bacteria biomarker panel of colorectal cancer. Sci Rep. 2021;11:2925.","journal-title":"Sci Rep"},{"key":"4500_CR96","doi-asserted-by":"publisher","first-page":"115","DOI":"10.4251\/wjgo.v10.i5.115","volume":"10","author":"K-S Cheung","year":"2018","unstructured":"Cheung K-S, Leung WK. Risk of gastric cancer development after eradication of Helicobacter pylori. World J Gastrointest Oncol. 2018;10:115.","journal-title":"World J Gastrointest Oncol"},{"key":"4500_CR97","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3390\/pathogens8010023","volume":"8","author":"JS Muhammad","year":"2019","unstructured":"Muhammad JS, Eladl MA, Khoder G. Helicobacter pylori-induced DNA methylation as an epigenetic modulator of gastric cancer: recent outcomes and future direction. Pathogens. 2019;8:23.","journal-title":"Pathogens"},{"key":"4500_CR98","doi-asserted-by":"publisher","first-page":"188309","DOI":"10.1016\/j.bbcan.2019.07.004","volume":"1872","author":"K Vinasco","year":"2019","unstructured":"Vinasco K, Mitchell HM, Kaakoush NO, Castano-Rodriguez N. Microbial carcinogenesis: lactic acid bacteria in gastric cancer. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer. 2019;1872:188309.","journal-title":"Biochimica et Biophysica Acta (BBA)-Reviews on Cancer"},{"key":"4500_CR99","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1186\/s12943-024-02174-w","volume":"23","author":"A Mannucci","year":"2024","unstructured":"Mannucci A, Goel A. Stool and blood biomarkers for colorectal cancer management: an update on screening and disease monitoring. Mol Cancer. 2024;23:259.","journal-title":"Mol Cancer"},{"key":"4500_CR100","doi-asserted-by":"publisher","DOI":"10.15252\/msb.20145645","volume":"10","author":"G Zeller","year":"2014","unstructured":"Zeller G, Tap J, Voigt AY, Sunagawa S, Kultima JR, Costea PI, et al. Potential of fecal microbiota for early\u2010stage detection of colorectal cancer. Mol Syst Biol. 2014;10:MSB145645.","journal-title":"Mol Syst Biol"},{"key":"4500_CR101","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pharmtox-061124-102218","author":"CAC Silva","year":"2025","unstructured":"Silva CAC, Fidelle M, Almonte AA, Derosa L, Zitvogel L. Gut microbiota\u2013related biomarkers in immuno-oncology. Annu Rev Pharmacol Toxicol. 2025. https:\/\/doi.org\/10.1146\/annurev-pharmtox-061124-102218.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"4500_CR102","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.4251\/wjgo.v15.i8.1424","volume":"15","author":"J-Q Fan","year":"2023","unstructured":"Fan J-Q, Zhao W-F, Lu Q-W, Zha F-R, Lv L-B, Ye G-L, et al. Fecal microbial biomarkers combined with multi-target stool DNA test improve diagnostic accuracy for colorectal cancer. World J Gastrointest Oncol. 2023;15:1424.","journal-title":"World J Gastrointest Oncol"},{"key":"4500_CR103","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13036-1","volume":"10","author":"JS Johnson","year":"2019","unstructured":"Johnson JS, Spakowicz DJ, Hong B-Y, Petersen LM, Demkowicz P, Chen L, et al. Evaluation of 16S rRNA gene sequencing for species and strain-level microbiome analysis. Nat Commun. 2019;10:5029.","journal-title":"Nat Commun"},{"key":"4500_CR104","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1136\/gutjnl-2015-309800","volume":"66","author":"J Yu","year":"2017","unstructured":"Yu J, Feng Q, Wong SH, Zhang D, Liang QY, Qin Y, et al. Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer. Gut. 2017;66:70\u20138.","journal-title":"Gut"},{"key":"4500_CR105","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/s41579-018-0029-9","volume":"16","author":"R Knight","year":"2018","unstructured":"Knight R, Vrbanac A, Taylor BC, Aksenov A, Callewaert C, Debelius J, et al. Best practices for analysing microbiomes. Nat Rev Microbiol. 2018;16:410\u201322.","journal-title":"Nat Rev Microbiol"},{"key":"4500_CR106","doi-asserted-by":"publisher","DOI":"10.1128\/AEM.02627-17","volume":"84","author":"J Pollock","year":"2018","unstructured":"Pollock J, Glendinning L, Wisedchanwet T, Watson M. The madness of microbiome: attempting to find consensus \u201cbest practice\u201d for 16S microbiome studies. Appl Environ Microbiol. 2018;84:e02627-02617.","journal-title":"Appl Environ Microbiol"},{"key":"4500_CR107","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/nbt.3935","volume":"35","author":"C Quince","year":"2017","unstructured":"Quince C, Walker AW, Simpson JT, Loman NJ, Segata N. Shotgun metagenomics, from sampling to analysis. Nat Biotechnol. 2017;35:833\u201344.","journal-title":"Nat Biotechnol"},{"key":"4500_CR108","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/nrmicro3451","volume":"13","author":"EA Franzosa","year":"2015","unstructured":"Franzosa EA, Hsu T, Sirota-Madi A, Shafquat A, Abu-Ali G, Morgan XC, et al. Sequencing and beyond: integrating molecular \u201comics\u201d for microbial community profiling. Nat Rev Microbiol. 2015;13:360\u201372.","journal-title":"Nat Rev Microbiol"},{"key":"4500_CR109","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1038\/nbt.3981","volume":"35","author":"R Sinha","year":"2017","unstructured":"Sinha R, Abu-Ali G, Vogtmann E, Fodor AA, Ren B, Amir A, et al. Assessment of variation in microbial community amplicon sequencing by the Microbiome Quality Control (MBQC) project consortium. Nat Biotechnol. 2017;35:1077\u201386.","journal-title":"Nat Biotechnol"},{"key":"4500_CR110","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-003334","volume":"9","author":"J Mao","year":"2021","unstructured":"Mao J, Wang D, Long J, Yang X, Lin J, Song Y, et al. Gut microbiome is associated with the clinical response to anti-PD-1 based immunotherapy in hepatobiliary cancers. J Immunother Cancer. 2021;9:e003334.","journal-title":"J Immunother Cancer"},{"key":"4500_CR111","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1126\/science.abb5920","volume":"371","author":"EN Baruch","year":"2021","unstructured":"Baruch EN, Youngster I, Ben-Betzalel G, Ortenberg R, Lahat A, Katz L, et al. Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients. Science. 2021;371:602\u20139.","journal-title":"Science"},{"key":"4500_CR112","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13092215","volume":"13","author":"J Veziant","year":"2021","unstructured":"Veziant J, Villeger R, Barnich N, Bonnet M. Gut microbiota as potential biomarker and\/or therapeutic target to improve the management of cancer: focus on colibactin-producing Escherichia coli in colorectal cancer. Cancers. 2021;13:2215.","journal-title":"Cancers"},{"key":"4500_CR113","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2021.644138","volume":"8","author":"Q Su","year":"2021","unstructured":"Su Q, Liu Q. Factors affecting gut microbiome in daily diet. Front Nutr. 2021;8:644138.","journal-title":"Front Nutr"},{"key":"4500_CR114","doi-asserted-by":"publisher","DOI":"10.1186\/s13568-020-01066-8","volume":"10","author":"O Bajinka","year":"2020","unstructured":"Bajinka O, Tan Y, Abdelhalim KA, \u00d6zdemir G, Qiu X. Extrinsic factors influencing gut microbes, the immediate consequences and restoring eubiosis. AMB Express. 2020;10:130.","journal-title":"AMB Express"},{"key":"4500_CR115","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101718","author":"Y Yang","year":"2024","unstructured":"Yang Y, Pei T, Hu X, Lu Y, Huang Y, Wan T, et al. Dietary vitamin B3 supplementation induces the antitumor immunity against liver cancer via biased GPR109A signaling in myeloid cell. Cell Rep Med. 2024. https:\/\/doi.org\/10.1016\/j.xcrm.2024.101718.","journal-title":"Cell Rep Med"},{"key":"4500_CR116","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1575452","volume":"16","author":"L Eiman","year":"2025","unstructured":"Eiman L, Moazzam K, Anjum S, Kausar H, Sharif EAM, Ibrahim WN. Gut dysbiosis in cancer immunotherapy: microbiota-mediated resistance and emerging treatments. Front Immunol. 2025;16:1575452.","journal-title":"Front Immunol"},{"key":"4500_CR117","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1684\/bdc.2011.1458","volume":"98","author":"G Sujol","year":"2011","unstructured":"Sujol G, Docquier A, Boulahtouf A, Castet-Nicolas A, Cavaill\u00e8s V. Vitamin B6 and cancer: from clinical data to molecularly mechanisms. Bull Cancer. 2011;98:1201\u20138.","journal-title":"Bull Cancer"},{"key":"4500_CR118","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1093\/bfgp\/elae013","volume":"23","author":"D Acharya","year":"2024","unstructured":"Acharya D, Mukhopadhyay A. A comprehensive review of machine learning techniques for multi-omics data integration: challenges and applications in precision oncology. Brief Funct Genomics. 2024;23:549\u201360.","journal-title":"Brief Funct Genomics"},{"issue":"8","key":"4500_CR119","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s43018-025-00991-6","volume":"6","author":"D Ferber","year":"2025","unstructured":"Ferber D, El Nahhas OS, W\u00f6lflein G, Wiest IC, Clusmann J, Le\u00dfmann M-E, et al. Development and validation of an autonomous artificial intelligence agent for clinical decision-making in oncology. Nat Cancer. 2025;6(8):1\u201313.","journal-title":"Nat Cancer"},{"key":"4500_CR120","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/s41575-020-0327-3","volume":"17","author":"G Cammarota","year":"2020","unstructured":"Cammarota G, Ianiro G, Ahern A, Carbone C, Temko A, Claesson MJ, et al. Gut microbiome, big data and machine learning to promote precision medicine for cancer. Nat Rev Gastroenterol Hepatol. 2020;17:635\u201348.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"4500_CR121","doi-asserted-by":"publisher","first-page":"25268","DOI":"10.1038\/s41598-025-08915-1","volume":"15","author":"J Wang","year":"2025","unstructured":"Wang J, Cong Y, Tang B, Liu J, Pu K. Integrative analysis of multi-omics data and gut microbiota composition reveals prognostic subtypes and predicts immunotherapy response in colorectal cancer using machine learning. Sci Rep. 2025;15:25268.","journal-title":"Sci Rep"},{"key":"4500_CR122","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.7150\/thno.125301","volume":"16","author":"S Muhammad","year":"2026","unstructured":"Muhammad S, Li M, Jia Q, Ijaz M, Liang S, Zeng W, et al. Advances in the engineering of living probiotics for cancer immunotherapy. Theranostics. 2026;16:1164.","journal-title":"Theranostics"},{"key":"4500_CR123","doi-asserted-by":"publisher","DOI":"10.1002\/cnr2.1870","volume":"6","author":"P Mishra","year":"2023","unstructured":"Mishra P, Badiyani VM, Jain S, Subramanian S, Maharaj SV, Kumar A, et al. Prebiotics: Ignored player in the fight against cancer. Cancer Reports. 2023;6:e1870.","journal-title":"Cancer Reports"},{"key":"4500_CR124","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s40164-024-00575-7","volume":"13","author":"Z Zhou","year":"2024","unstructured":"Zhou Z, Zheng J, Lu Y, Mai Z, Lin Y, Lin P, et al. Optimizing CD8+ T cell-based immunotherapy via metabolic interventions: a comprehensive review of intrinsic and extrinsic modulators. Exp Hematol Oncol. 2024;13:103.","journal-title":"Exp Hematol Oncol"},{"key":"4500_CR125","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14194796","volume":"14","author":"Z Dai","year":"2022","unstructured":"Dai Z, Fu J, Peng X, Tang D, Song J. Intestinal microbiota: the driving force behind advances in cancer immunotherapy. Cancers. 2022;14:4796.","journal-title":"Cancers"},{"key":"4500_CR126","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/joim.13238","volume":"290","author":"S Ghanem","year":"2021","unstructured":"Ghanem S, Kim CJ, Dutta D, Salifu M, Lim SH. Antimicrobial therapy during cancer treatment: beyond antibacterial effects. J Intern Med. 2021;290:40\u201356.","journal-title":"J Intern Med"},{"key":"4500_CR127","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1126\/science.add9667","volume":"378","author":"CR Gurbatri","year":"2022","unstructured":"Gurbatri CR, Arpaia N, Danino T. Engineering bacteria as interactive cancer therapies. Science. 2022;378:858\u201364.","journal-title":"Science"},{"key":"4500_CR128","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1021\/acs.accounts.4c00293","volume":"57","author":"P Liu","year":"2024","unstructured":"Liu P, Hu Q. Engineering cells for cancer therapy. Acc Chem Res. 2024;57:2358\u201371.","journal-title":"Acc Chem Res"},{"key":"4500_CR129","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/s41586-019-0878-z","volume":"565","author":"T Tanoue","year":"2019","unstructured":"Tanoue T, Morita S, Plichta DR, Skelly AN, Suda W, Sugiura Y, et al. A defined commensal consortium elicits CD8 T cells and anti-cancer immunity. Nature. 2019;565:600\u20135.","journal-title":"Nature"},{"key":"4500_CR130","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1016\/j.chom.2021.08.001","volume":"29","author":"A Montalban-Arques","year":"2021","unstructured":"Montalban-Arques A, Katkeviciute E, Busenhart P, Bircher A, Wirbel J, Zeller G, et al. Commensal Clostridiales strains mediate effective anti-cancer immune response against solid tumors. Cell Host Microbe. 2021;29:1573-1588. e1577.","journal-title":"Cell Host Microbe"},{"key":"4500_CR131","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14124193","volume":"14","author":"K Grafanaki","year":"2025","unstructured":"Grafanaki K, Maniatis A, Anastogianni A, Bania A, Pasmatzi E, Stathopoulos C. Nutrition and diet patterns as key modulators of metabolic reprogramming in melanoma immunotherapy. J Clin Med. 2025;14:4193.","journal-title":"J Clin Med"},{"key":"4500_CR132","doi-asserted-by":"publisher","DOI":"10.3390\/nu17111891","volume":"17","author":"AE Watson","year":"2025","unstructured":"Watson AE, Yusuf N. The influence of dietary factors on melanoma development and progression: a comprehensive review. Nutrients. 2025;17:1891.","journal-title":"Nutrients"},{"key":"4500_CR133","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-025-03604-9","volume":"25","author":"X Wang","year":"2025","unstructured":"Wang X, Huang Y, Yang Z, Yang Y, Wei F, Yan M, et al. Effect of probiotics combined with immune checkpoint suppressors and chemotherapeutic agents on digestive system function, intestinal immunity and prognosis in patients with metastatic colorectal carcinoma: a quasi-experimental study. BMC Gastroenterol. 2025;25:38.","journal-title":"BMC Gastroenterol"},{"key":"4500_CR134","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1603658","volume":"16","author":"Y Lu","year":"2025","unstructured":"Lu Y, Yuan H, Liang S, Li D, Jiang P, Wang X, et al. Microbial metabolite-driven immune reprogramming in tumor immunotherapy: mechanisms and therapeutic perspectives. Front Immunol. 2025;16:1603658.","journal-title":"Front Immunol"},{"key":"4500_CR135","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2025.1670598","volume":"12","author":"N Fuller-Shavel","year":"2025","unstructured":"Fuller-Shavel N, Davies EJ, Peleg Hasson S. Nutritional strategies in supporting immune checkpoint inhibitor, PI3K inhibitor, and tyrosine kinase inhibitor cancer therapies. Front Nutr. 2025;12:1670598.","journal-title":"Front Nutr"},{"key":"4500_CR136","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1456030","volume":"15","author":"S Lu","year":"2024","unstructured":"Lu S, Wang C, Ma J, Wang Y. Metabolic mediators: microbial-derived metabolites as key regulators of anti-tumor immunity, immunotherapy, and chemotherapy. Front Immunol. 2024;15:1456030.","journal-title":"Front Immunol"},{"key":"4500_CR137","doi-asserted-by":"crossref","unstructured":"Baruch, E.N.; Higbie, V.S.; Damania, A.V.; Neale, Z.R.; Chelvanambi, M.; Johnson, S.; Singh, B.; Day, A.; Wong, M.; Melendez, B. 1266 The gut microbiome enhances anti-PD-1 efficacy in a tumor-agnostic manner: results from a phase II trial of fecal microbiota transplantation and anti-PD-1 re-induction in MSI-H refractory cancers. 2024.","DOI":"10.1136\/jitc-2024-SITC2024.1266"},{"key":"4500_CR138","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1710880","volume":"16","author":"W Luo","year":"2025","unstructured":"Luo W, Li R, Pan C, Luo C. Gut microbiota\u2013derived metabolites in immunomodulation and gastrointestinal cancer immunotherapy. Front Immunol. 2025;16:1710880.","journal-title":"Front Immunol"},{"key":"4500_CR139","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1126\/science.aad1329","volume":"350","author":"M V\u00e9tizou","year":"2015","unstructured":"V\u00e9tizou M, Pitt JM, Daill\u00e8re R, Lepage P, Waldschmitt N, Flament C, et al. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science. 2015;350:1079\u201384.","journal-title":"Science"},{"key":"4500_CR140","doi-asserted-by":"publisher","first-page":"111931","DOI":"10.18632\/oncotarget.22953","volume":"8","author":"MP Kuczma","year":"2017","unstructured":"Kuczma MP, Ding Z-C, Li T, Habtetsion T, Chen T, Hao Z, et al. The impact of antibiotic usage on the efficacy of chemoimmunotherapy is contingent on the source of tumor-reactive T cells. Oncotarget. 2017;8:111931.","journal-title":"Oncotarget"},{"key":"4500_CR141","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37636-0","volume":"14","author":"JD Ransohoff","year":"2023","unstructured":"Ransohoff JD, Ritter V, Purington N, Andrade K, Han S, Liu M, et al. Antimicrobial exposure is associated with decreased survival in triple-negative breast cancer. Nat Commun. 2023;14:2053.","journal-title":"Nat Commun"},{"key":"4500_CR142","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s41591-019-0377-7","volume":"25","author":"BA Helmink","year":"2019","unstructured":"Helmink BA, Khan MAW, Hermann A, Gopalakrishnan V, Wargo JA. The microbiome, cancer, and cancer therapy. Nat Med. 2019;25:377\u201388.","journal-title":"Nat Med"},{"key":"4500_CR143","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.634511","volume":"12","author":"LJ Marcos-Zambrano","year":"2021","unstructured":"Marcos-Zambrano LJ, Karaduzovic-Hadziabdic K, Loncar Turukalo T, Przymus P, Trajkovik V, Aasmets O, et al. Applications of machine learning in human microbiome studies: a review on feature selection, biomarker identification, disease prediction and treatment. Front Microbiol. 2021;12:634511.","journal-title":"Front Microbiol"},{"key":"4500_CR144","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2025.1637071","volume":"12","author":"W Bahitham","year":"2025","unstructured":"Bahitham W, Banoun Y, Aljahdali M, Almuaiqly G, Bahshwan SM, Aljahdali L, et al. \u201cTrust your gut\u201d: exploring the connection between gut microbiome dysbiosis and the advancement of metabolic associated steatosis liver disease (MASLD)\/metabolic associated steatohepatitis (MASH): a systematic review of animal and human studies. Front Nutr. 2025;12:1637071.","journal-title":"Front Nutr"},{"key":"4500_CR145","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2025.1559870","volume":"15","author":"M Meyers","year":"2025","unstructured":"Meyers M, Stoffels CB, Frache G, Letellier E, Feucherolles M. Microbiome in cancer metastasis: biological insights and emerging spatial omics methods. Front Cell Infect Microbiol. 2025;15:1559870.","journal-title":"Front Cell Infect Microbiol"},{"key":"4500_CR146","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1093\/bib\/bbz155","volume":"22","author":"R Bharti","year":"2021","unstructured":"Bharti R, Grimm DG. Current challenges and best-practice protocols for microbiome analysis. Brief Bioinform. 2021;22:178\u201393.","journal-title":"Brief Bioinform"},{"key":"4500_CR147","doi-asserted-by":"publisher","DOI":"10.3390\/nu11071613","volume":"11","author":"RD Hills","year":"2019","unstructured":"Hills RD, Pontefract BA, Mishcon HR, Black CA, Sutton SC, Theberge CR. Gut microbiome: profound implications for diet and disease. Nutrients. 2019;11:1613.","journal-title":"Nutrients"},{"key":"4500_CR148","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/s41586-019-1238-8","volume":"569","author":"The integrative human microbiome project","year":"2019","unstructured":"The integrative human microbiome project. Nature. 2019;569:641\u20138.","journal-title":"Nature"},{"key":"4500_CR149","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s13059-019-1843-8","volume":"20","author":"KL Greathouse","year":"2019","unstructured":"Greathouse KL, Sinha R, Vogtmann E. DNA extraction for human microbiome studies: the issue of standardization. Genome Biol. 2019;20:212.","journal-title":"Genome Biol"},{"key":"4500_CR150","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s12672-025-02038-9","volume":"16","author":"Y Yang","year":"2025","unstructured":"Yang Y, Meng Y, Xu Z, Zhang Q, Li M, Kong F, et al. Leveraging microbiome signatures to predict tumor immune microenvironment and prognosis of patients with endometrial carcinoma. Discov Oncol. 2025;16:299.","journal-title":"Discov Oncol"},{"key":"4500_CR151","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15030794","volume":"15","author":"S Asokan","year":"2023","unstructured":"Asokan S, Cullin N, Stein-Thoeringer CK, Elinav E. CAR-T cell therapy and the gut microbiota. Cancers (Basel). 2023;15:794.","journal-title":"Cancers (Basel)"},{"key":"4500_CR152","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/ajg.2013.59","volume":"108","author":"Z Kassam","year":"2013","unstructured":"Kassam Z, Lee CH, Yuan Y, Hunt RH. Fecal microbiota transplantation forClostridium difficileInfection: systematic review and meta-analysis. Offl J Am Coll Gastroenterol. 2013;108:500\u20138.","journal-title":"Offl J Am Coll Gastroenterol"},{"key":"4500_CR153","unstructured":"Food, U. Drug Administration. Enforcement policy regarding investigational new drug requirements for use of fecal microbiota for transplantation to treat clostridioides difficile infection not responsive to standard therapies. 2025."},{"key":"4500_CR154","doi-asserted-by":"publisher","first-page":"39","DOI":"10.20517\/mrr.2025.45","volume":"4","author":"E Delannoy","year":"2025","unstructured":"Delannoy E, Grassart A, Daniel C. Gut bioengineered models to study host-microbiota-probiotics interactions. Microbiome Res Rep. 2025;4:39.","journal-title":"Microbiome Res Rep"},{"key":"4500_CR155","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1242\/dmm.017400","volume":"8","author":"T Nguyen","year":"2015","unstructured":"Nguyen T, Vieira-Silva S, Liston A, Raes J. How informative is the mouse for human gut microbiota research? Dis Model Mech. 2015;8:1\u201316.","journal-title":"Dis Model Mech"},{"key":"4500_CR156","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1038\/s41551-019-0397-0","volume":"3","author":"S Jalili-Firoozinezhad","year":"2019","unstructured":"Jalili-Firoozinezhad S, Gazzaniga FS, Calamari EL, Camacho DM, Fadel CW, Bein A, et al. A complex human gut microbiome cultured in an anaerobic intestine-on-a-chip. Nat Biomed Eng. 2019;3:520\u201331.","journal-title":"Nat Biomed Eng"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04500-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-026-04500-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04500-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T17:24:31Z","timestamp":1785518671000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-026-04500-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,27]]},"references-count":156,"alternative-id":["4500"],"URL":"https:\/\/doi.org\/10.1007\/s12094-026-04500-8","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,27]]},"assertion":[{"value":"18 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that there are no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This article is a review and does not involve human participants, animal experiments, patient samples, or unpublished clinical data.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}]}}